Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Moline

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Analytical Chemistry|September 23, 2017
A Microwave Flow Detector for Gradient Elution Liquid ChromatographyDuye Ye, Weizheng Wang, David Moline, et al.
NPJ Precision Oncology|September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastasesMegan L Ludwig, David Moline, Alec Horrmann, et al.
Oncotarget|July 25, 2025
Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancerAiden Deacon, Ava Gustafson, Allison Makovec, et al.
NPJ Precision Oncology|August 7, 2025
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
NPJ Precision Oncology|November 20, 2025
Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Analytical Chemistry|September 23, 2017
A Microwave Flow Detector for Gradient Elution Liquid ChromatographyDuye Ye, Weizheng Wang, David Moline, et al.
NPJ Precision Oncology|September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastasesMegan L Ludwig, David Moline, Alec Horrmann, et al.
Oncotarget|July 25, 2025
Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancerAiden Deacon, Ava Gustafson, Allison Makovec, et al.
NPJ Precision Oncology|August 7, 2025
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
NPJ Precision Oncology|November 20, 2025
Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Pageof 1